Objective: assessing the prognostic role of miR-20a-5p, in terms of clinical outcome, in a large multi-institutional cohort study. Methods: Tissue microarrays from 535 patients’ prostatectomy specimens were constructed. In situ hybridization was performed to assess the expression level of miR-20a-5p in different tissue subregions: tumor stroma (TS) and tumor epithelium (TE). In vitro analysis was performed on prostate cancer cell lines. Results: A high miR-20a-5p expression was found negatively in association with biochemical failure in TE, TS and TE + TS (p = 0.001, p = 0.003 and p = 0.001, respectively). Multivariable analysis confirmed that high miR-20a-5p expression in TE independently predicts dismal prognosis for biochemical failure (...
Prostate cancer is the most common cancer in men, and most patients have localized disease at the ti...
Abstract Background Recently, microRNA-20a (miR-20a) has been reported to influence the clinical fea...
PURPOSE: Prostate-specific antigen testing has led to overtreatment of prostate cancer (PCa). Only a...
Objective: assessing the prognostic role of miR-20a-5p, in terms of clinical outcome, in a large mul...
MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of variou...
MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of variou...
Prostate cancer accounts for extensive mortality and is the second most frequent cancer type occurri...
Due to insufficient prognostic tools, failure to predict aggressive prostate cancer (PC) has left pa...
Background. Previous literatures have investigated the change of miR-20a expression level in the pro...
Aim: microRNAs (miRNAs) are involved in various neoplastic diseases, including prostate cancer (PCs)...
microRNAs (miRNAs) are involved in various neoplastic diseases, including prostate cancer (PCs). The...
The role of miR-24-1-5p and its prognostic implications associated with prostate cancer are mainly u...
The complex genetics of cancer allows tumors to grow and spread undeterred by the control mechanisms...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
Prostate cancer is the most common cancer in men, and most patients have localized disease at the ti...
Abstract Background Recently, microRNA-20a (miR-20a) has been reported to influence the clinical fea...
PURPOSE: Prostate-specific antigen testing has led to overtreatment of prostate cancer (PCa). Only a...
Objective: assessing the prognostic role of miR-20a-5p, in terms of clinical outcome, in a large mul...
MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of variou...
MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of variou...
Prostate cancer accounts for extensive mortality and is the second most frequent cancer type occurri...
Due to insufficient prognostic tools, failure to predict aggressive prostate cancer (PC) has left pa...
Background. Previous literatures have investigated the change of miR-20a expression level in the pro...
Aim: microRNAs (miRNAs) are involved in various neoplastic diseases, including prostate cancer (PCs)...
microRNAs (miRNAs) are involved in various neoplastic diseases, including prostate cancer (PCs). The...
The role of miR-24-1-5p and its prognostic implications associated with prostate cancer are mainly u...
The complex genetics of cancer allows tumors to grow and spread undeterred by the control mechanisms...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. Th...
Prostate cancer is the most common cancer in men, and most patients have localized disease at the ti...
Abstract Background Recently, microRNA-20a (miR-20a) has been reported to influence the clinical fea...
PURPOSE: Prostate-specific antigen testing has led to overtreatment of prostate cancer (PCa). Only a...